ARCHIVES

Abraxane Combination Improves Survival In Treatment-Naïve Metastatic Disease

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: NCI Request for Applications

April 28, 2000

Who Writes NCI’s bypass Budget anyway>? Editor’s name Revealed

May 14, 1993

Cancer Organizations Continue Reform Lobbying: Target Issue Are Off-Label Drugs, Clinical Trials

March 26, 1993

Karlan To Succeed Hoskins As Chairman, DOD Ovarian Cancer Program Advisory Panel.

July 27, 2001

In Brief: Appropriations Bill Markups Due This Month, With Increases Seen For NCI, NIH, And AIDS

July 3, 1987

Therapeutic Modalities Improve Patient Quality of Life In Trials

February 27, 2004